Pando Bioscience vs Isomorphic Labs
Side-by-side comparison of features, pricing, and ratings
At a glance
| Dimension | Pando Bioscience | Isomorphic Labs |
|---|---|---|
| Industry Focus | Enzyme engineering for pharma manufacturing & diagnostics | Drug discovery (small molecule) for pharma |
| Key Technology | Generative AI + ultra-high-throughput screening | AlphaFold-based predictive & generative AI |
| Partnership Model | Custom enzyme engineering services + proprietary enzymes | Deep pharma collaborations (Novartis, J&J) |
| Speed/Cost Advantage | 75% faster; 80% lower screening costs | Not specified (partnership-based) |
| Pricing | Contact | Contact |
| Latest News | No recent news | Series B (Feb 2026), $600M investment (2025), J&J collaboration (Jan 2026), US operations (Jun 2025) |
Choose Pando Bioscience if your immediate need is faster, cheaper enzyme engineering for manufacturing or diagnostics, with a proven 75% speed boost and 80% cost reduction. Choose Isomorphic Labs if you're a large pharma seeking a cutting-edge AI drug discovery partner with AlphaFold pedigree and deep pockets ($600M+ investment). Most buyers will select based on application: enzymes vs. small molecules.
Gen-AI designed enzymes for pharma manufacturing and life science tools.
Visit Website
What real users say: Pando Bioscience vs Isomorphic Labs
Not marketing copy and not our opinion — a structured sweep of public discussion (reviews, forums, communities and video comments), showing what people praise and what they complain about for each tool.
Pando Bioscience
0 mentions · mixed
What users praise
- • Generative AI designs novel enzyme sequences not possible with directed evolution.
- • Ultra-high-throughput screens 1000-fold more variants than traditional methods.
- • Multi-property optimization simultaneously improves activity, stability, and manufacturability.
- • Claims 75% faster development and 80% lower screening costs.
What frustrates them
- • No real user feedback or independent reviews exist to verify claims.
- • Pricing is hidden behind contact sales, reducing transparency.
- • No integrations or platform details are provided for workflow compatibility.
- • Lack of community discussion makes it hard to gauge real-world performance.
Researched Jul 3, 2026
Isomorphic Labs
48 mentions across 3 sources · 82% positive
Hacker News, YouTube, Lemmy
What users praise
- • Built on the Nobel-winning AlphaFold, giving it instant credibility in structural biology.
- • Drug Design Engine extends beyond structure to generative molecule design, promising novel chemistry.
- • Deep partnerships with Novartis and J&J, with potential billions in royalties.
- • Interdisciplinary team of top ML and drug discovery experts, ensuring depth of expertise.
What frustrates them
- • Not accessible to individual researchers or small biotech due to partnership model only.
- • Proprietary nature of parts of its tech limits community scrutiny and independent validation.
- • CASP16 results suggest AlphaFold 3-based models aren't always better than older methods for protein-ligand interactions.
- • No marketed drugs yet; outcomes remain uncertain with royalties tied to long timelines.
Researched Aug 18, 2026
Who should pick which
- Pharma manufacturer needing optimized enzymes for drug productionPick: Pando Bioscience
Pando delivers 75% faster enzyme development and 80% lower screening costs, with multi-property optimization and custom engineering tailored for manufacturing.
- Diagnostic company developing enzyme-based assaysPick: Pando Bioscience
Pando's proprietary engineered enzymes for molecular biology and rapid iteration across millions of variants fit diagnostic reagent needs.
- Large pharma seeking AI-driven small molecule discovery partnerPick: Isomorphic Labs
Isomorphic's AlphaFold-based Drug Design Engine and proven collaborations (Novartis, J&J) are ideal for large-scale drug programs, backed by $600M investment.
- Biotech R&D team needing faster, cheaper enzyme engineeringPick: Pando Bioscience
Pando's integrated AI-screening loop provides rapid iteration and cost reduction (80% lower) compared to traditional methods.
- Research institution exploring digital biology frontiersPick: Isomorphic Labs
Isomorphic's digital simulation at scale and AlphaFold technology appeal to cutting-edge drug discovery research.
Frequently Asked Questions
Pando Bioscience vs Isomorphic Labs: which should you choose?
Choose Pando Bioscience if your immediate need is faster, cheaper enzyme engineering for manufacturing or diagnostics, with a proven 75% speed boost and 80% cost reduction. Choose Isomorphic Labs if you're a large pharma seeking a cutting-edge AI drug discovery partner with AlphaFold pedigree and deep pockets ($600M+ investment). Most buyers will select based on application: enzymes vs. small molecules.
What is the main difference between Pando Bioscience and Isomorphic Labs?
Pando focuses on enzyme engineering for manufacturing and diagnostics, using generative AI and high-throughput screening. Isomorphic focuses on small molecule drug discovery via AlphaFold-based AI, partnering with pharma giants.
Which company offers more cost-effective services?
Pando claims 80% lower screening costs and 75% faster development. Isomorphic's costs are not disclosed but involve large-scale pharma partnerships.
Can I buy a software license from Isomorphic Labs?
No. Isomorphic operates solely through deep pharma collaborations; it does not offer a standalone software product.
Does Pando Bioscience provide off-the-shelf enzymes?
Yes, Pando offers proprietary engineered enzymes for molecular biology, in addition to custom engineering services.
Has Isomorphic Labs announced any recent funding?
Yes, it raised $600M in 2025 and a Series B in February 2026 (amount undisclosed).
Which company is better for a startup with limited budget?
Neither offers transparent pricing. Pando may be more accessible for specific enzyme projects given its cost-efficiency claims.
Do both companies use generative AI?
Yes, but Pando applies it to enzyme sequence design, while Isomorphic uses it for novel molecule generation.
Is Isomorphic Labs a subsidiary of DeepMind?
It is a spinout from DeepMind, building on AlphaFold technology, but operates independently.
More Pando Bioscience or Isomorphic Labs comparisons
Angle and Isomorphic Labs serve completely different domains—Angle is a free, niche pose-measurement tool for fitness professionals, while Isomorphic Labs is an enterprise AI drug discovery platform f
Choose Ray if you need an adaptive, low-barrier AI personal trainer for flexible, voice-guided workouts — it's ideal for busy individuals wanting consistency without gym intimidation. Choose Isomorphi
These tools are polar opposites in audience and purpose. Ironclaw AI Vision is a free, offline-first PWA for individual fitness tracking with AI coaching and meal planning – ideal for privacy-consciou
These tools serve completely different markets. CalBye is a consumer nutrition app for individuals wanting effortless calorie tracking via photos, while Isomorphic Labs is an enterprise drug discovery
Isomorphic Labs and Swimio serve completely different worlds: one is a high-stakes pharma AI platform for billion-dollar drug programs, the other a consumer fitness app for swimmers. Choose based on y
MediSphere and Isomorphic Labs serve completely different healthcare verticals. Choose MediSphere if you run a small clinic needing AI-powered administration, no-show prediction, and EHR. Choose Isomo
Explore each tool further
Browse these categories
One email a week — new tools, honest comparisons, no spam.
Last reviewed: July 3, 2026